Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways
Mutations in the presenilin (PS/PSEN) genes cause early-onset familial Alzheimer's disease (AD) by enhancing cerebral accumulation of amyloid-beta (A beta) peptides and microtubule-associated protein tau (MAPT). How PS mutations affect A beta generation is well characterized, but the precise ce...
| Autores: | , , , , , , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2026 |
| País: | España |
| Recursos: | Institut d'Investigació i Innovació Parc Taulí (I3PT) |
| Repositório: | r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí |
| OAI Identifier: | oai:dnet:r-i3pt______::97ee246b1635a1c380619f947361011e |
| Acesso em linha: | https://i3pt.portalinvestigacion.com/publicaciones/7178 |
| Access Level: | Acceso aberto |
| Palavra-chave: | Alzheimer's disease Autophagy Proteasome gamma-Secretase Neurodegeneration Proteostasis Tauopathies |
| id |
ES_e400d4f3ce2c315c6a3e0a3f3d95aa4d |
|---|---|
| oai_identifier_str |
oai:dnet:r-i3pt______::97ee246b1635a1c380619f947361011e |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathwaysdel Ser-Badia, ASoto-Faguás, CMVecino, RVendrell, CMolina-Porcel, LSánchez-Valle, RRodríguez-Alvarez, JVicario, CSaura, CAAlzheimer's diseaseAutophagyProteasomegamma-SecretaseNeurodegenerationProteostasisTauopathiesMutations in the presenilin (PS/PSEN) genes cause early-onset familial Alzheimer's disease (AD) by enhancing cerebral accumulation of amyloid-beta (A beta) peptides and microtubule-associated protein tau (MAPT). How PS mutations affect A beta generation is well characterized, but the precise cellular mechanisms by which PS dysfunction drives neuronal tau pathology are not fully understood. Here, we investigated the mechanisms linking PS/gamma-secretase-dependent tau pathology and autophagy/proteasome by employing pathological, imaging and molecular approaches in human brains, fibroblasts and induced pluripotent stem cells (iPSC)-derived neurons from PSEN1-linked familial AD carriers, and in a novel neuronal PS-deficient tauopathy transgenic mouse. We found enhanced levels and colocalization of pathological phosphorylated tau (pTau) and ubiquitin factor p62 in the hippocampus of dementia patients with familial AD-linked PSEN1 mutations, corticobasal degeneration and Pick's disease, suggesting disrupted proteasomal degradation in tauopathies. Human primary fibroblasts from PSEN1 G206D and/or L286P carriers showed elevated LC3-I and autolysosomes indicating autophagy flux alterations. Human iPSC-derived neurons harboring the familial-AD linked PSEN1 G206D mutation showed increased aggregated tau and reduced secreted tau, whereas pharmacological proteasome inhibition reduced significantly total and pTau (Ser396/404) while increasing its release. Consistently, proteasomal inhibition decreased intracellular tau and pTau and promoted tau release in human tau-expressing neurons through a mechanism that partially depends on PS. In the hippocampus of neuronal PS-deficient mice, Akt activation and GSK3 beta inhibition were associated with elevated levels of phosphorylated and aggregated tau and the ubiquitin-binding protein p62. In conclusion, PS function is required for autophagy/proteasome-mediated tau elimination in neurons, whereas that FAD-linked PSEN1 mutations cause progressive tau pathology by disrupting the proteasome and autophagy/lysosomal pathways.BMC2026info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://i3pt.portalinvestigacion.com/publicaciones/7178Acta Neuropathologica CommunicationsISSN: 20515960reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulíinstname:Institut d'Investigació i Innovació Parc Taulí (I3PT)Inglésinfo:eu-repo/semantics/openAccessoai:dnet:r-i3pt______::97ee246b1635a1c380619f947361011e2026-06-21T15:30:37Z |
| dc.title.none.fl_str_mv |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| title |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| spellingShingle |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways del Ser-Badia, A Alzheimer's disease Autophagy Proteasome gamma-Secretase Neurodegeneration Proteostasis Tauopathies |
| title_short |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| title_full |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| title_fullStr |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| title_full_unstemmed |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| title_sort |
Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways |
| dc.creator.none.fl_str_mv |
del Ser-Badia, A Soto-Faguás, CM Vecino, R Vendrell, C Molina-Porcel, L Sánchez-Valle, R Rodríguez-Alvarez, J Vicario, C Saura, CA |
| author |
del Ser-Badia, A |
| author_facet |
del Ser-Badia, A Soto-Faguás, CM Vecino, R Vendrell, C Molina-Porcel, L Sánchez-Valle, R Rodríguez-Alvarez, J Vicario, C Saura, CA |
| author_role |
author |
| author2 |
Soto-Faguás, CM Vecino, R Vendrell, C Molina-Porcel, L Sánchez-Valle, R Rodríguez-Alvarez, J Vicario, C Saura, CA |
| author2_role |
author author author author author author author author |
| dc.subject.none.fl_str_mv |
Alzheimer's disease Autophagy Proteasome gamma-Secretase Neurodegeneration Proteostasis Tauopathies |
| topic |
Alzheimer's disease Autophagy Proteasome gamma-Secretase Neurodegeneration Proteostasis Tauopathies |
| description |
Mutations in the presenilin (PS/PSEN) genes cause early-onset familial Alzheimer's disease (AD) by enhancing cerebral accumulation of amyloid-beta (A beta) peptides and microtubule-associated protein tau (MAPT). How PS mutations affect A beta generation is well characterized, but the precise cellular mechanisms by which PS dysfunction drives neuronal tau pathology are not fully understood. Here, we investigated the mechanisms linking PS/gamma-secretase-dependent tau pathology and autophagy/proteasome by employing pathological, imaging and molecular approaches in human brains, fibroblasts and induced pluripotent stem cells (iPSC)-derived neurons from PSEN1-linked familial AD carriers, and in a novel neuronal PS-deficient tauopathy transgenic mouse. We found enhanced levels and colocalization of pathological phosphorylated tau (pTau) and ubiquitin factor p62 in the hippocampus of dementia patients with familial AD-linked PSEN1 mutations, corticobasal degeneration and Pick's disease, suggesting disrupted proteasomal degradation in tauopathies. Human primary fibroblasts from PSEN1 G206D and/or L286P carriers showed elevated LC3-I and autolysosomes indicating autophagy flux alterations. Human iPSC-derived neurons harboring the familial-AD linked PSEN1 G206D mutation showed increased aggregated tau and reduced secreted tau, whereas pharmacological proteasome inhibition reduced significantly total and pTau (Ser396/404) while increasing its release. Consistently, proteasomal inhibition decreased intracellular tau and pTau and promoted tau release in human tau-expressing neurons through a mechanism that partially depends on PS. In the hippocampus of neuronal PS-deficient mice, Akt activation and GSK3 beta inhibition were associated with elevated levels of phosphorylated and aggregated tau and the ubiquitin-binding protein p62. In conclusion, PS function is required for autophagy/proteasome-mediated tau elimination in neurons, whereas that FAD-linked PSEN1 mutations cause progressive tau pathology by disrupting the proteasome and autophagy/lysosomal pathways. |
| publishDate |
2026 |
| dc.date.none.fl_str_mv |
2026 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://i3pt.portalinvestigacion.com/publicaciones/7178 |
| url |
https://i3pt.portalinvestigacion.com/publicaciones/7178 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
BMC |
| publisher.none.fl_str_mv |
BMC |
| dc.source.none.fl_str_mv |
Acta Neuropathologica Communications ISSN: 20515960 reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí instname:Institut d'Investigació i Innovació Parc Taulí (I3PT) |
| instname_str |
Institut d'Investigació i Innovació Parc Taulí (I3PT) |
| reponame_str |
r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí |
| collection |
r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869422553236242432 |
| score |
15,812429 |